BiomX Inc.
PHGE
$1.62
$0.074.52%
AMEX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 234.14% | -63.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 343.36% | -81.99% | |||
| Operating Income | -317.75% | 81.99% | |||
| Income Before Tax | 79.91% | -43.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 79.91% | -43.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 80.29% | -43.51% | |||
| EBIT | -317.75% | 81.99% | |||
| EBITDA | -856.94% | 90.64% | |||
| EPS Basic | 95.05% | -10.72% | |||
| Normalized Basic EPS | 95.52% | -478.13% | |||
| EPS Diluted | 95.05% | -10.72% | |||
| Normalized Diluted EPS | 95.52% | -478.13% | |||
| Average Basic Shares Outstanding | 296.08% | 30.19% | |||
| Average Diluted Shares Outstanding | 296.08% | 30.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||